A positive magnetic resonance spectroscopic imaging with negative initial biopsy may predict future detection of prostate cancer

Indian Journal of Urology

Volumn 28, Issue 2, 2012, Pages 243-245

  Dwivedi, Durgesh Kumar ^a   Kumar, Virendra ^a   Javali, Tarun ^a   Dinda, Amit K ^a   Thulkar, Sanjay ^a   Jagannathan, Naranmangalam R ^a   Kumar, Rajeev ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Biopsy; magnetic resonance spectroscopic imaging; prostate cancer; prostate specific antigen

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; ARTICLE; BIOCHEMISTRY; CANCER DIAGNOSIS; CANCER SIZE; CASE REPORT; COHORT ANALYSIS; DIAGNOSTIC ACCURACY; HUMAN; HUMAN TISSUE; MALE; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PROSTATE BIOPSY; PROSTATE CANCER; TRANSRECTAL ULTRASONOGRAPHY;

EID: 84872238530     PISSN: 09701591     EISSN: 19983824     Source Type: Journal    
DOI: 10.4103/0970-1591.98487     Document Type: Article

References (11)

1. Schröder FH, Hugosson J, Roobol MJ, Tammela TL, Ciatto S, Nelen V, et al. ERSPC Investigators. Screening and prostate-cancer mortality in a randomized European study. N Engl J Med 2009;360:1320-8
2. Jagannathan NR, Kumar V, Kumar R, Thulkar S. Role of magnetic resonance methods in the evaluation of prostate cancer: An Indian perspective. MAGMA 2008;21:393-407
3. Kumar R, Nayyar R, Kumar V, Gupta NP, Hemal AK, Jagannathan NR, et al. Potential of magnetic resonance spectroscopic imaging in predicting absence of prostate cancer in men with serum prostate-specific antigen between 4 and 10 ng/ml: A follow-up study. Urology 2008;72:859-63
4. Kurhanewicz J, Vigneron DB, Hricak H, Narayan P, Carroll P, Nelson SJ. Three-dimensional H-1 MR spectroscopic imaging of the in situ human prostate with high (0.24-0.7-cm3) spatial resolution. Radiology 1996;19:795-805
5. Kumar V, Jagannathan NR, Kumar R, Thulkar S, Gupta SD, Hemal AK, et al. Transrectal ultrasound-guided biopsy of prostate voxels identified as suspicious of malignancy on three-dimensional (1)H MR spectroscopic imaging in patients with abnormal digital rectal examination or raised prostate specific antigen level of 4-10 ng/ml. NMR Biomed 2007;20:11-20
6. Ahmed HU, Kirkham A, Arya M, Illing R, Freeman A, Allen C, et al. Is it time to consider a role for MRI before prostate biopsy? Nat Rev Clin Oncol 2009;6:197-206
7. Kumar V, Jagannathan NR, Kumar R, Nayyar R, Thulkar S, Gupta SD, et al. Potential of (1)H MR spectroscopic imaging to egregate patients who are likely to show malignancy of the peripheral zone of the prostate on biopsy. J Magn Reson Imaging 009;30:842-8
8. Kubota Y, Kamei S, Nakano M, Ehara H, Deguchi T, Tanaka O. The potential role of prebiopsy magnetic resonance imaging combined with prostate-specific antigen density in the detection of prostate cancer. Int J Urol 2008;15:322-6
9. Le bihan D. Looking into the functional architecture of the brain with diffusion MRI. Nat Rev Neurosci 2003;4:469-80
10. Engelbrecht MR, Huisman HJ, Laheij RJ, Jager GJ, van Leenders GJ, Hulsbergen-Van De Kaa CA, et al. Discrimination of rostate ancer from normal peripheral zone and central gland tissue by using dynamic contrast enhanced MR imaging. Radiology 003;229:248-54
11. Labanaris AP, Zugor V, Smiszek R, Nützel R, Kühn R, Engelhard K. Guided e-MRI prostate biopsy can solve he discordance between Gleason score biopsy and radical prostatectomy pathology. Magn Reson Imaging 2010;28:943-6